Literature DB >> 23983960

Risperidone-induced acromegaly: a case report.

Ayşe Koroglu, Cicek Hocaoglu.   

Abstract

Today, considering their adverse side effects, the first-generation antipsychotics have been replaced by the new-generation antipsychotics (also known as second-generation antipsychotic agents). The superiority of new-generation antipsychotics compared with first-generation antipsychotic agents in terms of side effects, especially movement disorders, are acknowledged by clinicians. But in recent years during the use of second-generation antipsychotic agents, endocrine side effects have been noteworthy. In our study with a diagnosis of paranoid schizophrenia treated with risperidone for 14 years and operated with the diagnosis of pituitary macroadenoma, a 32-year-old female patient is presented in the light of the literature examining the framework of the history of disease.

Entities:  

Keywords:  acromegaly; endocrine side effects; risperidone

Year:  2012        PMID: 23983960      PMCID: PMC3736930          DOI: 10.1177/2045125311433581

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  20 in total

Review 1.  The role of outcomes data for assessing the expertise of a pituitary surgeon.

Authors:  Kiarash Shahlaie; Nancy McLaughlin; Amin B Kassam; Daniel F Kelly
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-08       Impact factor: 3.243

2.  Consensus statement: medical management of acromegaly.

Authors:  S Melmed; F Casanueva; F Cavagnini; P Chanson; L A Frohman; R Gaillard; E Ghigo; K Ho; P Jaquet; D Kleinberg; S Lamberts; E Laws; G Lombardi; M C Sheppard; M Thorner; M L Vance; J A H Wass; A Giustina
Journal:  Eur J Endocrinol       Date:  2005-12       Impact factor: 6.664

Review 3.  Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design.

Authors:  Roberto Coccurello; Anna Moles
Journal:  Pharmacol Ther       Date:  2010-05-20       Impact factor: 12.310

Review 4.  Growth hormone-secreting adenomas: pathology and cell biology.

Authors:  M Beatriz S Lopes
Journal:  Neurosurg Focus       Date:  2010-10       Impact factor: 4.047

5.  Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.

Authors:  Ana Szarfman; Joseph M Tonning; Jonathan G Levine; P Murali Doraiswamy
Journal:  Pharmacotherapy       Date:  2006-06       Impact factor: 4.705

Review 6.  Risperidone versus other atypical antipsychotics for schizophrenia.

Authors:  Katja Komossa; Christine Rummel-Kluge; Sandra Schwarz; Franziska Schmid; Heike Hunger; Werner Kissling; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

Review 7.  Metabolic syndrome with the atypical antipsychotics.

Authors:  Pornpoj Pramyothin; Lalita Khaodhiar
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-10       Impact factor: 3.243

Review 8.  Prolactin awareness: an essential consideration for physical health in schizophrenia.

Authors:  Angel L Montejo
Journal:  Eur Neuropsychopharmacol       Date:  2008-05       Impact factor: 4.600

Review 9.  Acromegaly pathogenesis and treatment.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2009-11-02       Impact factor: 14.808

Review 10.  Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects.

Authors:  U Halbreich; B J Kinon; J A Gilmore; L S Kahn
Journal:  Psychoneuroendocrinology       Date:  2003-01       Impact factor: 4.905

View more
  3 in total

Review 1.  Curious cases: Acromegaly and schizophrenia: an incidental association?

Authors:  Pedro Iglesias; Carmen Bernal; Juan J Díez
Journal:  Schizophr Bull       Date:  2014-03-06       Impact factor: 9.306

2.  Sexual dysfunction in outpatients with schizophrenia in Turkey: a cross-sectional study.

Authors:  Cicek Hocaoglu; Fatmagul H Celik; Gokhan Kandemir; Hulya Guveli; Bulent Bahceci
Journal:  Shanghai Arch Psychiatry       Date:  2014-12

3.  Chlorpromazine-Induced Hyperprolactinemia on Rat's Uterus.

Authors:  Zahra Zamani; Samad Zare; Rajabali Sadrkhanlou; Abbas Ahmadi; Elham Movahed
Journal:  Iran Biomed J       Date:  2015-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.